Alphatec Holdings (ATEC) Non-Current Deffered Revenue (2021 - 2025)
Alphatec Holdings (ATEC) reported Non-Current Deffered Revenue of $2.2 million for Q4 2025, down 30.37% on a YoY basis from $3.1 million in Q4 2024, and down 30.37% sequentially from $3.1 million in Q4 2024.
Alphatec Holdings (ATEC) Non-Current Deffered Revenue (2021 - 2025) Analysis & Trends
Alphatec Holdings (ATEC) has 5 years of Non-Current Deffered Revenue data on file, last reported at $2.2 million in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Deffered Revenue fell 30.37% year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (down 30.37% YoY), and the FY2025 full-year result was $2.2 million, down 30.37% from the prior year.
- Non-Current Deffered Revenue slipped to $2.2 million in Q4 2025, from $3.1 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $3.1 million in Q4 2024 to a low of $2.2 million in Q4 2025.
- A 5-year average of $2.8 million and a median of $2.8 million in 2021 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue increased 20.42% in 2024 and slumped 30.37% in 2025, its largest moves.
- Tracing ATEC's Non-Current Deffered Revenue over 5 years: stood at $2.9 million in 2021, then gained by 3.45% to $3.0 million in 2022, then decreased by 13.33% to $2.6 million in 2023, then grew by 20.42% to $3.1 million in 2024, then tumbled by 30.37% to $2.2 million in 2025.
- Business Quant data shows ATEC's Non-Current Deffered Revenue at $2.2 million in Q4 2025, $3.1 million in Q4 2024, and $2.6 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.18 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 2.71 Mn |